Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 6/20 | 0.46 |
| ▸ | BTK | Q06187 | 13/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | YES1 | P07947 | 1/20 | 0.40 |
| ▸ | FGR | P09769 | 1/20 | 0.40 |
| ▸ | TEC | P42680 | 1/20 | 0.40 |
| ▸ | BMX | P51813 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3262289 | 1.00 | EGFR (0.46) | EGFRBTKHTR1ADRD2HTR2A | |
| SCHEMBL3262494 | 0.81 | BTK (0.46) | EGFRBTKHTR1ADRD2HTR2A | |
| SCHEMBL2492737 | 0.78 | BTK (0.41) | EGFRBTK | |
| SCHEMBL1322596 | 0.77 | BTK (0.73) | BTKYES1FGRTECBMX | |
| SCHEMBL3260832 | 0.77 | SYK (0.42) | EGFRBTK | |
| SCHEMBL3260836 | 0.77 | SYK (0.42) | EGFRBTK | |
| SCHEMBL13303668 | 0.77 | BTK (0.44) | BTKYES1FGRTECBMX | |
| SCHEMBL3262697 | 0.77 | BTK (0.44) | BTKHTR1ADRD2HTR2A | |
| SCHEMBL3262701 | 0.77 | BTK (0.44) | BTKHTR1ADRD2HTR2A | |
| SCHEMBL9984561 | 0.75 | BTK (0.44) | BTKHTR1ADRD2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010068806-A1 | AMIDE DERIVATIVES AS BTK INHIBITORS IN THE TREATMENT OF ALLERGIC, AUTOIMMUNE AND INFLAMMATORY DISORDERS AS WELL AS CANCER | CGI PHARMACEUTICALS, INC. (US) | 2010-06-17 | — | — | WO | claimed |